OVERLOOKED

Recalls › Medicines & devices

Class IIOngoing

Zydus Pharmaceuticals (USA) Inc recalls Hydrocortisone Sodium Succinate for Injection

Recall date · record updated Oct 21, 2026 · Source: U.S. Food and Drug Administration (openFDA drug enforcement)

What to do

Check your product against the names and codes above. The FDA enforcement record lists the recall as voluntary: firm initiated; it does not state a consumer remedy, so follow the firm’s notice or the FDA link.

Company
Zydus Pharmaceuticals (USA) Inc
Reason
Failed Impurities/Degradation Specifications.
Hazard
FDA Class II: may cause temporary or medically reversible adverse health consequences (FDA definition).
Who’s affected
Nationwide within the United States
Where
Nationwide
Official notice
www.accessdata.fda.gov/scripts/ires/index.cfm?Event=100017…

Products

  1. Hydrocortisone Sodium Succinate for Injection, USP 100 mg/vial, 1 Vial, Rx Only, Manufactured by: Zydus Lifesciences Ltd., Vadodara - 391510 India, Distributed by: Zydus Pharmaceuticals (USA) Inc., Pennington, NJ 08534, NDC 70710-1907-1.

    Codes/lots: Lot #: LB00047A, LB00048A, Exp. Date 03/2028Quantity: 70776 vialsRecall no. D-0039-2027Class II

Update history

  1. First listed on OVERLOOKED from the official record.

When the agency expands or changes this recall, we update this page and log the change here.

Proof: raw official record (JSON) · fetched from FDA API

More Medicines & devices recalls